{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:42:57Z","timestamp":1780922577420,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clineuro.2020.105737","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T11:58:00Z","timestamp":1581940680000},"page":"105737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pharmacologic prophylaxis for heterotopic ossification following spinal cord injury: A systematic review and meta-analysi"],"prefix":"10.1016","volume":"193","author":[{"given":"Yagiz Ugur","family":"Yolcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Wahood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshit","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald K.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle J.","family":"Gerberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-396X","authenticated-orcid":false,"given":"Mohamad","family":"Bydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2020.105737_bib0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1302\/0301-620X.74B2.1544955","article-title":"Heterotopic ossification after spinal cord injury. Epidemiology and risk factors","volume":"74","author":"Wittenberg","year":"1992","journal-title":"J. Bone Joint Surg. Br."},{"issue":"7","key":"10.1016\/j.clineuro.2020.105737_bib0010","first-page":"471","article-title":"Para-articular ossification in spinal cord injury","volume":"22","author":"Freehafer","year":"1966","journal-title":"Med. Serv. J. Can."},{"key":"10.1016\/j.clineuro.2020.105737_bib0015","first-page":"497","article-title":"Para-osteo-arthropathies des paraplegiques par lesion medullaire; etude clinique et radiographique","volume":"5","author":"Dejerne","year":"1918","journal-title":"Ann. Med."},{"key":"10.1016\/j.clineuro.2020.105737_bib0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sc.2009.175","article-title":"A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury","volume":"48","author":"Teasell","year":"2010","journal-title":"Spinal Cord"},{"issue":"22","key":"10.1016\/j.clineuro.2020.105737_bib0025","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1097\/BRS.0000000000002680","article-title":"Clinical prediction rule for heterotopic ossification of the hip in patients with spinal cord injury","volume":"43","author":"Suero","year":"2018","journal-title":"Spine."},{"issue":"4","key":"10.1016\/j.clineuro.2020.105737_bib0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/PL00002399","article-title":"Fractionated and single-dose radiotherapy for heterotopic bone formation in patients with spinal cord injury. A phase-I\/II study. Strahlentherapie und Onkologie","volume":"177","author":"Sautter-Bihl","year":"2001","journal-title":"Strahlenther. Onkol."},{"issue":"13","key":"10.1016\/j.clineuro.2020.105737_bib0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2106\/JBJS.N.01056","article-title":"Heterotopic ossification: basic-science principles and clinical correlates","volume":"97","author":"Ranganathan","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"issue":"242","key":"10.1016\/j.clineuro.2020.105737_bib0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00003086-198905000-00016","article-title":"Resection of heterotopic ossification in patients with spinal cord injuries","author":"Garland","year":"1989","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.clineuro.2020.105737_bib0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5371\/hp.2018.30.2.86","article-title":"Ankylosing neurogenic myositis ossificans of the hip: a case series and review of literature","volume":"30","author":"Yoon","year":"2018","journal-title":"Hip Pelvis"},{"issue":"1","key":"10.1016\/j.clineuro.2020.105737_bib0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0030-1250688","article-title":"[Treatment of heterotopic ossification after spinal cord injury - clinical outcome after single-dose radiation therapy]","volume":"149","author":"Citak","year":"2011","journal-title":"Z. Orthop. Unfall."},{"issue":"10","key":"10.1016\/j.clineuro.2020.105737_bib0055","first-page":"660","article-title":"Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification","volume":"31","author":"Banovac","year":"1993","journal-title":"Paraplegia."},{"key":"10.1016\/j.clineuro.2020.105737_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ : British Medical Journal."},{"issue":"7414","key":"10.1016\/j.clineuro.2020.105737_bib0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.clineuro.2020.105737_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.clineuro.2020.105737_bib0075","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj."},{"key":"10.1016\/j.clineuro.2020.105737_bib0080","series-title":"SBOCDPJWVLM. Newcastle-Ottawa Quality Assessment Scale","author":"Wells","year":"2014"},{"issue":"7454","key":"10.1016\/j.clineuro.2020.105737_bib0085","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"Bmj."},{"issue":"7","key":"10.1016\/j.clineuro.2020.105737_bib0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.sc.3101166","article-title":"Prevention of heterotopic ossification after spinal cord injury with indomethacin","volume":"39","author":"Banovac","year":"2001","journal-title":"Spinal Cord"},{"issue":"2","key":"10.1016\/j.clineuro.2020.105737_bib0095","first-page":"146","article-title":"Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report)","volume":"14","author":"Stover","year":"1976","journal-title":"Paraplegia."},{"issue":"2","key":"10.1016\/j.clineuro.2020.105737_bib0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00002060-199204000-00005","article-title":"Warfarin in prevention of heterotopic ossification","volume":"71","author":"Buschbacher","year":"1992","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"3","key":"10.1016\/j.clineuro.2020.105737_bib0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41393-018-0199-3","article-title":"Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review","volume":"57","author":"Zakrasek","year":"2019","journal-title":"Spinal Cord"},{"issue":"12","key":"10.1016\/j.clineuro.2020.105737_bib0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.sc.3101628","article-title":"Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib)","volume":"42","author":"Banovac","year":"2004","journal-title":"Spinal Cord"},{"issue":"2","key":"10.1016\/j.clineuro.2020.105737_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/2045772314Y.0000000213","article-title":"Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury","volume":"38","author":"Ploumis","year":"2015","journal-title":"J. Spinal Cord Med."},{"issue":"8","key":"10.1016\/j.clineuro.2020.105737_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ncprheum0252","article-title":"Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2","volume":"2","author":"Kozak","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"2","key":"10.1016\/j.clineuro.2020.105737_bib0125","first-page":"159","article-title":"Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?","volume":"10","author":"Vasileiadis","year":"2010","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"6","key":"10.1016\/j.clineuro.2020.105737_bib0130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3928\/01477447-20110427-23","article-title":"COX-2 inhibitors for the prevention of heterotopic ossification after THA","volume":"34","author":"Vasileiadis","year":"2011","journal-title":"Orthopedics."},{"issue":"4","key":"10.1016\/j.clineuro.2020.105737_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003321.pub3","article-title":"Pharmacological interventions for treating acute heterotopic ossification","author":"Haran","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.clineuro.2020.105737_bib0140","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sc.2009.175","article-title":"A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury","volume":"48","author":"Teasell","year":"2010","journal-title":"Spinal Cord"},{"issue":"4","key":"10.1016\/j.clineuro.2020.105737_bib0145","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.arth.2016.10.030","article-title":"Galante JO. Heterotopic ossification prophylaxis after total hip arthroplasty: randomized trial of 400 vs 700 cGy","volume":"32","author":"Liu","year":"2017","journal-title":"J. Arthroplasty"},{"issue":"3","key":"10.1016\/j.clineuro.2020.105737_bib0150","first-page":"202","article-title":"The incidence of ectopic bone formation in post-traumatic paraplegic patients of different racial groups","volume":"14","author":"Scher","year":"1976","journal-title":"Paraplegia."},{"issue":"10","key":"10.1016\/j.clineuro.2020.105737_bib0155","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.sc.3101761","article-title":"Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases","volume":"43","author":"Schuetz","year":"2005","journal-title":"Spinal Cord"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720300809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720300809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:32:04Z","timestamp":1759588324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720300809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":31,"alternative-id":["S0303846720300809"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105737","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic prophylaxis for heterotopic ossification following spinal cord injury: A systematic review and meta-analysi","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105737"}}